Outset Medical 3Q 2026: Revenue $33.6M, Net loss $14.7M, EPS $(0.78) — 10-Q Summary

Outset Medical reported third-quarter 2026 revenue of $33.6 million, up 14% year over year, while its net loss narrowed to $14.7 million from $17.8 million a year earlier. Diluted loss per share was $0.78, compared with $1 in the prior-year quarter.

Financial Highlights

• Revenue was $33.6M, compared with $29.4M in the prior-year quarter; YoY change 14%.
• Net loss was $14.7M, compared with a $17.8M loss in the prior-year quarter; the loss narrowed 18%.
• Diluted EPS was $(0.78), compared with $(1.00) in the prior-year quarter.

Business Highlights

• Nine-month revenue increased 3% to $93.1M. Quarterly product revenue grew 15%, led by higher console and consumable sales, while nine-month product revenue declined 1%.
• Service revenue rose 12% in the quarter and 13% for the first nine months, primarily reflecting growth in the installed console base.
• Gross margin improved to 40.7% in the quarter and 41.9% year to date, driven mainly by stronger service margins and cost efficiencies.
• The company plans to broaden acute and post-acute adoption, increase utilization at existing sites, and scale home dialysis support.

Original SEC Filing: Outset Medical, Inc. [ OM ] - 10-Q - Nov. 04, 2026